GreenStar Biosciences Corp. (CSE: GSTR) and CannabCo stay ahead of the competition thanks to new cultivation technologies

Since the legalization of medicinal and recreational cannabis in Canada last year, the companies picked up the opportunity this regulation offers and the market became flooded with cannabis businesses. In order to stay ahead of the competition, they are trying to find their niche, by releasing new products, coming up with irresistible brands or securing patented technologies.

The latter is the strategy adopted by two companies that appear as interesting options for investors, GreenStar Biosciences Corp. (CSE: GSTR) and CannabCo.

GreenStar Biosciences

GreenStar Biosciences Corp. (CSE: GSTR) is an investment company that specializes in identifying local cannabis competitors and helping them succeed. GreenStar partners with several companies that touch in every aspect of the product life cycle.

Through the joint venture with Progressive Herbs Inc. called Capri, the company has licenced access to their proprietary cultivation technology. It allows them to produce cannabis with the highest cannabinoid levels in the market at very low costs, as it doesn’t require cutting edge equipment and can be done in sub-optimal facilities. It is also grown faster than any other harvest. The plants were grown in Cowlitz’s (another partner of GreenStar) warehouse in Washington State and tested by an independent laboratory confirming its quality and cultivation advantages.

The harvest time is also much shorter. The tested plants were grown in about 72 days, which allows up to five harvests per year. Other producers can execute three to four harvests per year.

GreenStar is an exclusive holder of the licence to use Capri’s cultivation technology but looking at its success, they will soon start selling the license to other producers, securing a new revenue stream.

Thanks to Capri, GreenStar positions itself as one of the most promising cannabis competitors in the market with high prospects of growth in the near future. Considering their assets, growth potential and the fact that the company is trading at a low price at the moment, it is a great moment for investment in their stocks.

CannabCo

As the Canadian company CannabCo from Ontario announced in a press release, it is working together with an as yet unknown partner on a technology for the production of an almost odourless cannabis strain. The variety would be the first of its kind and, according to CannabCo, is in great demand. After receiving the license from Health Canada, CannabCo has the exclusive right to use the technology in Canada to produce the odourless cannabis strain.

Originally the production technology was developed under the name “PURECANN” for the medical market to make smoking cannabis more pleasant. Usually you have to cough when smoking cannabis, especially inexperienced users have problems with inhaling the smoke, says Mark Novak, board member and manager at CannabCo. The special processing technology makes smoking cannabis much easier. In addition, the odourless cannabis variety should also simplify the application without losing important properties.

In addition, the processing method eliminates the typical smell of cannabis. And not only during smoking, but also during storage and packaging.

Over the last two years, the technology has been further developed and is now in a position to open up a market that does not yet exist, says Novak.

According to CannabCo, PURECANN, the odourless cannabis variety, has various properties:

• No perceptible smell of the dried product during storage
• Significantly less cannabis odor when burned
• Less scratchy, which contributes to a pleasant smoking sensation
• Weaker “hangover” the next day

The PURECANN technology developed by CannabCo is initially only used by the Canadian company itself. It is still unclear to what extent other companies will gain access. So far CannabCo has the exclusive right for the application of the technology within the production in Canada.